KUALA LUMPUR: Duopharma Biotech Bhd
today said the government has accepted the tender offer from its wholly owned subsidiary Duopharma Marketing Sdn Bhd (DMktg) to supply Insugen, a human insulin formulation, to all Ministry of Health’s hospitals, district health offices and clinics.
The group said the supply contract, worth RM375.17 million, would be for a period of three years commencing on Dec 17, 2021 until Dec 16, 2024.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
